CMS officials have delivered an early gift to help providers like you map out where they should focus their compliance efforts — not just for 2024, but for 2025 as well.
Report: 20 percent of nursing home residents receive antipsychotics
By
Kristen Fischer
Mar 20, 2024
A new report highlights the high number of nursing home residents who are prescribed antipsychotic drugs. Authors of the report say that, in most cases, the drugs aren’t clinically justified.
Study: Focusing on neurology — not just psychiatry — helps cut antipsychotic use in SNF residents
By
Kristen Fischer
Sep 29, 2023
A neurology-focused effort to reduce antipsychotic drugs in skilled nursing facilities lowered usage by 68% in people with behavioral and psychological symptoms of dementia, according to a new report published...
Disadvantages, understaffing combine to ratchet up nursing homes’ antipsychotic reliance: study
By
Josh Henreckson
Apr 25, 2024
Nursing homes in disadvantaged neighborhoods are more likely to rely on antipsychotics, especially when understaffed, compared to those in more affluent areas, according to a new study in Jama Network...
Study: Medicare warnings cut antipsychotics in nursing home residents, others
By
Kristen Fischer
Apr 26, 2024
When Medicare sent warning letters urging doctors to lower antipsychotic prescriptions, it worked, a report published Thursday in JAMA Network Open found.
Antipsychotic prescribing higher at nursing homes in disadvantaged areas: study
By
Kristen Fischer
Apr 25, 2024
Nursing homes in disadvantaged communities are more likely to overmedicate residents with antipsychotics, according to a study published Wednesday in JAMA Network Open.
With ‘hundreds’ of facilities audited over schizophrenia, CMS pursues harsher antipsychotics stance
By
Kimberly Marselas
Jan 19, 2024
With half of nursing homes audited in a new process admitting to misdiagnosing schizophrenia patients, the Centers for Medicare & Medicaid Services is extending its drive to reduce the use of certain drugs...
Antipsychotic drugs overprescribed to people with Alzheimer’s, dementia living at home
By
Kristen Fischer
Sep 07, 2023
People with Alzheimer’s disease and related dementias who receive home health are likely getting prescribed antipsychotics too often, according to a new study. The research was published Wednesday in...
FDA fast-tracked dementia drug with known harms, reporter says
By
Kristen Fischer
Aug 18, 2023
An article in The BMJ is sounding the alarm that the US Food and Drug Administration fast-tracked approval for the dementia drug Rexulti (brexpiprazole) — even though trials show the drug is harmful.
CMS leader mum on staffing mandate, delivers ‘back to basics’ message
By
James M. Berklan
Nov 08, 2023
A CMS leader steered clear of staffing mandate talk but highlighted a nursing home workforce campaign, renewed survey priorities, discharge processes and much more Tuesday.